Duodenal‐jejunal bypass surgery induces hepatic lipidomic alterations associated with ameliorated hepatic steatosis in mice. Issue 9 (26th July 2016)

• Record Type: Journal Article
• Authors: Shang, Jin; Castro‐Perez, Jose M.; Shen, Xiaolan; Zhu, Yonghua; Liu, Haiying; Qian, Ying; Previs, Stephen; Howard, Andrew D.; Erion, Mark; Kelley, David E.; Wang, Liangsu
• Is Part Of: Obesity. Volume 24:Issue 9(2016)
• Page Start: 1938
• Page End: 1945
• Publication Date: 2016-07-26
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.21583
• Languages: English
• ISSNs: 1930-7381

Abstract

Abstract : Objective: Bariatric surgery induces weight loss and improvement of insulin resistance; one aspect of both is an amelioration of hepatic steatosis. This study was undertaken to assess the changes in the hepatic lipidome after duodenal‐jejunal bypass (DJB) surgery. Methods: A DJB surgical model was developed and characterized in diet‐induced obese mice. In comparison with sham‐operated mice, an unbiased lipidomic profiling of hepatic lipids was performed together with measurements of gene expression within key pathways of hepatic lipid metabolism. Results: In the liver of DJB mice, a dramatic reduction (by 77%) in hepatic triacylglycerols was observed. Global lipidomic profiling identified marked decreases of triacylglycerols comprised of medium length fatty acids and with low double bond content. Specific diacylglycerol species were also among the most dramatic decreases in hepatic lipids, whereas lysophosphatidic acids and phosphatidic acids were increased. Expression of fatty acid transporter and lipogenic genes was down‐regulated. Conclusions: From in‐depth analysis of hepatic lipid composition, specific lipid intermediates were identified that are preferentially changed following DJB surgery. These changes were most likely due to DJB‐induced weight loss, and only further studies will be able to distinguish weight loss‐dependent from weight loss‐independent changes.